Thrombocytopenia in #ICU, PLOT‑ICU study
🩸observed in 43% critically ill adults associated with worse outcomes (½ at admission, with increased mortality)
🩸PLT transfusions frequently used (23%) if severe/very severe thrombocytopenia, most prophylactic
🔓https://t.co/NFI1GsttTQ
Our updated systematic review assessing the effects of haloperidol on mortality and serious adverse events in critically ill patients with delirium is now available online. Data from #AIDICU#EuRIDICE trials are included with existing treatment trials👇
https://t.co/waN25jTxQU
On this day, we acknowledge International Women's Day and the enormous contribution of women in intensive care medicine. We celebrate your impact as healthcare leaders and changemakers. @anzics#IWD2023#WomenInICU
Congratulations to the 🍀CLOVERS team🍀. No benefit or harm from fluid restriction in sepsis with hypotension after 1-3L fluid resuscitation. Questions remain regarding septic shock subgroup and long-term/functional outcomes. https://t.co/9ueDXGG2d9
New paper in @CritCareMed: to inform selection and handling of patient-important outcomes other than mortality in @INCEPTdk, we conducted a scoping review summarising selection, definition, and handling of these outcomes in contemporary ICU trials (1/..) https://t.co/neh9MmFVx8
IV vitamin C has been hypothesized to mitigate tissue injury due to oxidative stress, and thus to improve outcomes, in patients with sepsis. Studies to date have shown mixed results. New research findings are summarized in a short video. https://t.co/mcUGrh0a9B
A huge shout-out to Rob and his team for making #CCR22 possible - what an honour to be part of this magical event! BEST critical care conference in the 🌍 Your spirit is just another level! Thank you is a too small word 🙏🏾@CritCareReviews#PartOfSomethingBigger#BetterTogether
1. We perform trials to answer important questions to improve care of our patients 2. It takes a team of engaged people and infrastructure for trial success 3. Collaboration and mentorship are fundamental building blocks for #2 … so many great examples of 1-3 @CritCareReviews
@BodilSRasmussen presenting the long-term outcomes of the #HOTICU trial in Belfast #CCR22#LONGHOTtrial@CRIC_Int_Care
Quality of life & mortality (https://t.co/6xtIRzZclJ) + new data on long-term pulmonary and cognitive function after #ICU admission for respiratory failure.
1. We perform trials to answer important questions to improve care of our patients 2. It takes a team of engaged people and infrastructure for trial success 3. Collaboration and mentorship are fundamental building blocks for #2 … so many great examples of 1-3 @CritCareReviews
The #CLASSIC trial results are out today. Presented brilliantly by @TineMeyhoff at #CCR2, who have created a wonderful forum at #TitanicBelfast for interesting and inspiring discussions afterwards.
In this trial, a restrictive approach to intravenous fluid administration in critically ill patients with septic shock did not reduce mortality. #CCR22 https://t.co/UfY1936Qwb